hesperidin has been researched along with cardiovascular agents in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erer, D; Ereren, E; Gokgoz, L; Halit, V; Iriz, E; Oktar, L; Poyraz, A; Soncul, H; Vural, C | 1 |
| Bottino, DA; Bouskela, E; Milhomens, AL; Pires, CE; Porto, CL; Sicuro, F; Xavier, SS | 1 |
| Avril, L; Enrici, E; Enriquez, E; Guex, JJ; Lis, C; Taïeb, C | 1 |
| Allaert, FA; Cazaubon, M; Clavel, T; Escourrou, P; Hugue, C; Renaudin, JM | 1 |
| Aun, R; Belczak, SQ; Beserra, J; Campos, W; Nering, G; Sincos, IR | 1 |
| Nikolaichuk, AI; Tsukanov, YT | 1 |
4 trial(s) available for hesperidin and cardiovascular agents
| Article | Year |
|---|---|
Changes on venous diameter and leg perimeter with different clinical treatments for moderate chronic venous disease: evaluation using Duplex scanning and perimeter measurements.
Topics: Adult; Anthropometry; Ascorbic Acid; Brazil; Cardiovascular Agents; Chi-Square Distribution; Chronic Disease; Chymotrypsin; Disability Evaluation; Drug Combinations; Female; Hesperidin; Humans; Lower Extremity; Middle Aged; Pain; Pain Measurement; Phytosterols; Popliteal Vein; Saphenous Vein; Stockings, Compression; Time Factors; Treatment Outcome; Trypsin; Ultrasonography, Doppler, Duplex; Vascular Diseases | 2009 |
Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study).
Topics: Adult; Aged; Argentina; Ascorbic Acid; Cardiovascular Agents; Chalcones; Chronic Disease; Drug Combinations; Female; Hesperidin; Humans; Logistic Models; Male; Mexico; Middle Aged; Odds Ratio; Plant Preparations; Prospective Studies; Quality of Life; Risk Assessment; Risk Factors; Ruscus; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venous Insufficiency | 2010 |
Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).
Topics: Activities of Daily Living; Analysis of Variance; Ascorbic Acid; Cardiovascular Agents; Chalcones; Chi-Square Distribution; Drug Therapy, Combination; Female; France; Hesperidin; Humans; Plant Extracts; Plethysmography; Predictive Value of Tests; Recovery of Function; Ruscus; Treatment Outcome; Ultrasonography, Doppler; Venous Insufficiency | 2011 |
Veno-active drugs for chronic venous disease: A randomized, double-blind, placebo-controlled parallel-design trial.
Topics: Biomechanical Phenomena; Brazil; Cardiovascular Agents; Chronic Disease; Coumarins; Diosmin; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Foot Joints; Hesperidin; Humans; Hydroxyethylrutoside; Male; para-Aminobenzoates; Plethysmography; Quality of Life; Range of Motion, Articular; Recovery of Function; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venous Insufficiency | 2014 |
2 other study(ies) available for hesperidin and cardiovascular agents
| Article | Year |
|---|---|
Effects of calcium dobesilate and diosmin-hesperidin on apoptosis of venous wall in primary varicose veins.
Topics: Adult; Aged; Apoptosis; bcl-2-Associated X Protein; Calcium Dobesilate; Cardiovascular Agents; Diosmin; Drug Combinations; Female; Hesperidin; Humans; Male; Middle Aged; Preoperative Care; Proto-Oncogene Proteins c-bcl-2; Saphenous Vein; Treatment Outcome; Tumor Suppressor Protein p53; Varicose Veins | 2008 |
[Transitory (evening) venous reflux in patients with intracutaneous varicosity and medicamentous correction thereof].
Topics: Adult; Cardiovascular Agents; Diosmin; Drug Combinations; Female; Flavonoids; Hesperidin; Humans; Lower Extremity; Quality of Life; Russia; Severity of Illness Index; Telangiectasis; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Varicose Veins | 2016 |